Dynamic Hydrogel Injectability via Catalyst Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Injectable hydrogels face a dilemma in achieving both high injectability and long-term stability, as fast crosslink exchange enhances injectability but compromises stability, while slow exchange improves stability but hampers injectability, making it challenging to protect cells during injection and provide a stable scaffold post-injection.

Innovation Solution

A biocompatible organic catalyst is used to modulate the dynamic properties of hyaluronic acid-based hydrogels through dynamic covalent hydrazone crosslinking, accelerating crosslink exchange during injection and slowing it down post-injection, maintaining network stability and mechanical properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If fast crosslink exchange is used to enhance injectability, then the hydrogel can be readily ejected through the needle, but the long-term stability of the hydrogel network is compromised

Engineering Contradiction:
ImproveinjectabilityVSAvoidnetwork stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

A biocompatible catalyst acts as an intermediary to temporarily accelerate crosslink exchange during injection, enabling the hydrogel to flow through the needle. After injection, the catalyst diffuses away, allowing the natural slow exchange rate to dominate and provide long-term stability. This mediator approach resolves the contradiction by introducing a temporary facilitator that is removed after serving its purpose.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The hydrogel's crosslink exchange rate is made dynamic rather than static. During injection, the exchange rate is temporarily increased through catalyst presence to enable flow. Post-injection, the exchange rate naturally decreases to provide stability. This dynamic adjustment of the exchange rate allows the system to adapt to different operational requirements at different times.

Inventive Principle:
Principle #15Dynamics

2Stability of the object's composition

If slow crosslink exchange is used to improve stability, then the hydrogel network remains stable, but injectability is compromised requiring excessive force

Engineering Contradiction:
Improvenetwork stabilityVSAvoidinjectability
Core Design Contradiction:
Stability of the object's compositionVSEase of operation

Solution Approach 1:

The catalyst serves as a temporary intermediary that bridges the gap between the inherently slow natural exchange rate and the fast exchange rate needed for injection. By introducing this mediator during the injection process only, the system can achieve both injectability and stability without permanently compromising either property.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The catalyst is pre-incorporated into the hydrogel formulation before injection. This preliminary action ensures that the catalyst is already present and ready to accelerate crosslink exchange at the moment injection is needed, eliminating the need for external catalyst application during the injection process and ensuring uniform acceleration throughout the hydrogel.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If dynamic crosslinking is used to enable injectability, then the hydrogel can flow through the needle, but cell protection during injection is reduced

Engineering Contradiction:
ImproveinjectabilityVSAvoidcell damage during injection
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The catalyst acts as a temporary mediator that enables controlled dynamic crosslink exchange during injection. This controlled dynamics allows the hydrogel to flow smoothly through the needle while maintaining sufficient network integrity to protect encapsulated cells from mechanical damage, resolving the contradiction between injectability and cell protection.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach enables hydrogels to be readily injectable while ensuring long-term stability and cell viability, supporting cell adhesion and growth, by temporally controlling crosslink exchange kinetics without altering the network structure or modulus.

Implementation Method 1

The catalyst accelerates the formation and exchange of hydrazone bonds, enhancing injectability

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

rapidly diffuses away from the hydrogel after injection to retard the exchange and improve the long-term stability

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS10220096B2Injectable and stable hydrogels with dynamic properties modulated by biocompatible catalysts
Publication Date: 2019.03.05 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US10220096B2 patent drawing
  • US10220096B2 patent drawing
  • US10220096B2 patent drawing

AI summary

A hydrogel composition includes: (1) a polymer network including a first water-soluble polymer and a second water-soluble polymer that are crosslinked through dynamic bonds; and (2) a catalyst to modulate a rate of exchange of crosslinking of the polymer network.